HOLSINGER LESLIEofficer: Executive Vice Presidentofficer: Executive Vice President
Common Stock
40,000
$0.27
$10,800
Sale
HOLSINGER LESLIEofficer: Executive Vice Presidentofficer: Executive Vice President
Common Stock
40,000
$31.14
$1,245,520
Option
HOLSINGER LESLIEofficer: Executive Vice Presidentofficer: Executive Vice President
Stock Option (Right to Buy)
40,000
$0.27
$10,800
Sale
HOLSINGER LESLIEofficer: Executive Vice Presidentofficer: Executive Vice President
Common Stock
40,000
N/A
N/A
Sale
HOLSINGER LESLIEofficer: Executive Vice Presidentofficer: Executive Vice President
Common Stock
40,000
$31.14
$1,245,520
Option
HOLSINGER LESLIEofficer: Executive Vice Presidentofficer: Executive Vice President
Common Stock
3,500
$0.27
$945
Option
HOLSINGER LESLIEofficer: Executive Vice Presidentofficer: Executive Vice President
Stock Option (Right to Buy)
3,500
$0.27
$945
Purchase
EPIQ CAPITAL GROUP, LLCother: Former 10% Ownerother: Former 10% Owner
Common Stock
2,440
$44.06
$107,506
Purchase
EPIQ CAPITAL GROUP, LLCother: Former 10% Ownerother: Former 10% Owner
Common Stock
6,600
$44.32
$292,512
Purchase
LAMOND DAVIDdirectordirector
Common Stock
49,125
$43.11
$2,117,779
Purchase
LAMOND DAVIDdirectordirector
Common Stock
49,125
$43.11
$2,117,779
Sale
PFIZER INC10 percent owner10 percent owner
Common Stock
370,000
$40.18
$14,866,600
Option
DETKE MICHAEL J.officer: Chief Medical Officerofficer: Chief Medical Officer
Common Stock
5,515
$6.91
$38,109
Option
DETKE MICHAEL J.officer: Chief Medical Officerofficer: Chief Medical Officer
Stock Option (Right to Buy)
5,515
$6.91
$38,109
Purchase
EPIQ CAPITAL GROUP, LLCother: Former 10% Ownerother: Former 10% Owner
Common Stock
2,085
$55.9
$116,552
Purchase
EPIQ CAPITAL GROUP, LLCother: Former 10% Ownerother: Former 10% Owner
Common Stock
520
$55.8
$29,016
Purchase
EPIQ CAPITAL GROUP, LLCother: Former 10% Ownerother: Former 10% Owner
Common Stock
6,085
$57.61
$350,557
Purchase
LAMOND DAVIDdirectordirector
Common Stock
39,200
$55.31
$2,168,074
Purchase
LAMOND DAVIDdirectordirector
Common Stock
39,200
$18.81
$737,156
Purchase
LAMOND DAVIDdirectordirector
Common Stock
5,448
$49.94
$272,068
Purchase
LAMOND DAVIDdirectordirector
Common Stock
5,448
$41.09
$223,853
Option
DETKE MICHAEL J.officer: Chief Medical Officerofficer: Chief Medical Officer
Stock Option (Right to Buy)
5,515
$6.91
$38,109
Option
DETKE MICHAEL J.officer: Chief Medical Officerofficer: Chief Medical Officer
Common Stock
5,515
$6.91
$38,109
Option
DETKE MICHAEL J.officer: Chief Medical Officerofficer: Chief Medical Officer
Stock Option (Right to Buy)
17,231
$6.91
$119,066
Option
DETKE MICHAEL J.officer: Chief Medical Officerofficer: Chief Medical Officer
Common Stock
17,231
$6.91
$119,066
Purchase
EPIQ CAPITAL GROUP, LLCother: Former 10% Ownerother: Former 10% Owner
Common Stock
4,110
$24.87
$102,212
Purchase
EPIQ CAPITAL GROUP, LLCother: Former 10% Ownerother: Former 10% Owner
Common Stock
5,820
$25.69
$149,516
Purchase
EPIQ CAPITAL GROUP, LLCother: Former 10% Ownerother: Former 10% Owner
Common Stock
4,200
$26.5
$111,279
Purchase
EPIQ CAPITAL GROUP, LLCother: Former 10% Ownerother: Former 10% Owner
Common Stock
1,400
$26.37
$36,919
Purchase
PFIZER INC10 percent owner10 percent owner
Common Stock
50,000
$17
$850,000
Purchase
RYAN UNA Sdirectordirector
Common Stock
2,875
$17
$48,875
Purchase
YOUNG KEVINdirectordirector
Common Stock
30,000
$17
$510,000
Purchase
MCLOUGHLIN MARGARETdirectordirector
Common Stock
550
$17
$9,350
Purchase
EPIQ CAPITAL GROUP, LLCother: Former 10% Ownerother: Former 10% Owner
Common Stock
17,200
$27.01
$464,624
Showing 50 to 86 of 86 results.
Insider trading
Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.
Who is insider?
Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.